Australia markets open in 9 hours 8 minutes

Boule Diagnostics AB (publ) (BDABF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.51000.0000 (0.00%)
As of 11:59AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 35.57M
Enterprise value 47.26M
Trailing P/E 40.83
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.58
Price/book (mrq)6.47
Enterprise value/revenue 0.08
Enterprise value/EBITDA 0.72

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 30.00%
S&P500 52-week change 323.57%
52-week high 37.8400
52-week low 33.5100
50-day moving average 37.8400
200-day moving average 37.8400

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 538.83M
Implied shares outstanding 638.83M
Float 828.76M
% held by insiders 127.29%
% held by institutions 148.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 406 May 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 4.37%
Operating margin (ttm)9.93%

Management effectiveness

Return on assets (ttm)3.59%
Return on equity (ttm)5.33%

Income statement

Revenue (ttm)571.33M
Revenue per share (ttm)14.71
Quarterly revenue growth (yoy)-0.70%
Gross profit (ttm)N/A
EBITDA 60.64M
Net income avi to common (ttm)24.98M
Diluted EPS (ttm)0.1900
Quarterly earnings growth (yoy)189.50%

Balance sheet

Total cash (mrq)37.28M
Total cash per share (mrq)0.96
Total debt (mrq)166.17M
Total debt/equity (mrq)34.98%
Current ratio (mrq)1.38
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)51.38M
Levered free cash flow (ttm)-29.56M